Clinical Trial Update: POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus [Phase 2]

View source ↗

Summary

Phase IIa trial in endometrial carcinoma evaluating temsirolimus (POEM STUDY) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Carcinoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: MedSIR | Conditions: Carcinoma, Endometrioid, mTOR Protein | Phase 2 | Status: COMPLETED